A reassortment of genetic information from RNA viruses with segmented genomes (e.g., arenaviruses, bunyaviruses, orthomyxoviruses, orbiviruses, and reoviruses) can occur within cells infected by two different viral strains (3, 6, 13, 27) . The phenomenon of reassortment has been exploited to define the function of viral genes in pathogenesis (6, 27) . For example, Fields and Greene (6) have shown that each of the three viral outer-capsid proteins of mammalian reoviruses has a distinct and specialized role in the pathogenesis of the relevant infection of mice, and Shope et al. (22) have linked the pathogenicity of bunyaviruses in mice with the M RNA segment. The reassortment of genomic RNAs from segmented RNA viruses also occurs in vivo. One isolate of human influenza virus has been established as a reassortant between an animal and a human influenza virus (27) , and genetic reassortment of influenza A viruses in the intestinal tracts of ducks with mixed infections (8) and of bunyaviruses (1, 25) , reoviruses, and orbiviruses (24, 28 ) has also been established.
Lymphocytic choriomeningitis virus (LCMV) is the prototype arenavirus and contains two single-stranded RNA species, L and S, with approximate molecular weights of 2.85 x 106 and 1.35 x 106, respectively (5) . We have recently obtained and characterized reassortants between the Armstrong (ARM) and WE strains of LCMV. Utilizing reassortants and parental strains of LCMV, we have shown that the perturbation of growth hormone synthesis in C3H/St mice maps to the S-RNA segment of LCMV ARM (17) and that the L-RNA segment of LCMV WE is important for virus replication in vivo and is associated with the fatal acute disease that follows the infection of adult guinea pigs (16) . We report herein that LCMV reassortants with the WE/ARM or the TRAUB/ARM genotype (ratios are the L-ARM segment/S-RNA segment) cause lethal disease after the inoculation of neonatal BALB/c WEHI mice, but, in contrast, parental strains or reciprocal reassortants do not. The disease, which is characterized by inhibition of growth and death, reflects the induction of interferon and subsequent liver necrosis.
MATERIALS AND METHODS
Mice. BALB/c WEHI (H-2d) mice and homologous nude (nulnu) athymic mice on BALB/c WEHI background were obtained from the breeding colony at Scripps Clinic and Research Foundation.
Virus. The origins of the LCMV ARM CA1371, WE, and TRAUB strains used in this study have been described elsewhere (5) . Reassortants between LCMV ARM and LCMV WE were generated and characterized as reported previously (15) ; reassortants between LCMV ARM and LCMV TRAUB were obtained by a similar protocol. Virus stocks of the parental (ARM/ARM, WE/WE, and TRAUB/TRAUB) and reassortant (ARM/WE, ARM/ TRAUB, WE/ARM, and TRAUB/ARM) genotypes were cloned and triple-plaque purified. Thereafter, a stock was prepared through one passage in BHK-21 cells. Infectious LCMV was quantitated by plaque (PFU) assay on Vero cell monolayers (16) .
Interferon titration. Serum samples from test mice were treated at pH 2 for 24 h to inactivate the virus. Interferon was assayed as previously described (9) on monolayers of mouse L929 cells challenged with 500 PFU of vesicular stomatitis virus. One of our interferon units equals two interferon reference units. Sheep antiserum to mouse L-cell interferon (G024501568) and control antiserum (sheep) to mouse L-cell interferon (G025501568) were from the National Institutes of Health, Bethesda, Md. The interferon neutralizing titer of the sheep antiserum to mouse L-cell interferon was 300,000 versus 8 to 10 reference units of murine interferon-a and -,B.
Cytotoxic T-lymphocyte assay. Single-spleen-cell suspensions, free from erythrocytes, were prepared in complete RPMI medium and tested for cytotoxicity on uninfected and LCMV-infected BALB CL-7 (H-2d) and MC57 (H-2b) fibroblasts as described elsewhere (Y. Riviere bCulture fluids from dually infected BHK-21 cells (48 h postinfection) were treated with 2.11.10 monoclonal antibody before progeny clones were isolated.
Monoclonal antibody 2.11.10 is directed against glycoprotein GP1 of LCMV ARM (2).
Progeny clones derived from coinfection were double-plaque purified on Vero cell monolayers, and passage 1 stocks were made in BHK-21 cells. d The genotypes of the LCMV progeny clones were determined by Northern transfer of viral RNA and hybridization with 32P-labeled cDNA probes specific for the L and S segments of the ARM strains as described previously (23) .
Histopathological studies. Tissues were removed from animals anesthetized with ether and sacrificed at increasing intervals after infection. When whole-body sections were performed, mice were bled after ether anesthesia, and the skin was removed before the fixation step. All samples for histology were fixed in Bouin solution, stained with hematoxylin-eosin, and examined by light microscopy. (ii) Histological examination. Sagittal and parasagittal sections of the whole body from control and infected mice on day 7 or days 14 to 16 after inoculation with either parental or reassortant viruses were studied initially. Abnormal histological changes were noted only in the livers. For the following experiments, sections of three to four livers from WE/ARM-or TRAUB/ARM-infected BALB/c WEHI mice were performed at days 3, 6 to 7, 9 to 10, and 14 to 16 after inoculation. Histological examination of these liver sections showed a marked steatosis, with small foci of necrosis by day 6 after infection. The liver lesion was maximal at days 9 to 10; i.e., the lesion was extensive and was characterized by subcapsular necrosis (Fig. 1 ). At days 14 to 16, foci of necrotic areas were observed in the livers of surviving mice. No lesion was noted when mice were infected with the parental viruses (ARM/ARM, WE/WE, and TRAUB/ TRAUB) or with the reciprocal reassortant genotypes (ARM/WE and ARM/TRAUB).
RESULTS

Generation
(iii) Determination of virus and interferon titers in serum and liver. The foregoing results show that newborn BALB/c WEHI mice infected with the WE/ARM or TRAUB/ARM genotype died within 3 weeks of birth with extensive liver necrosis, whereas newborns infected with the reciprocal reassortant genotype or the parental viruses did not die. Virus titers were then measured in the sera and livers of newborns injected with the ARM/ARM, WE/WE, ARM/WE, and WE/ARM genotypes. The sera of mice infected with the WE/ARM genotype contained the most infectious virus of any group at days 5 and 6 after infection ( Fig. 2A) , and their livers had at least 10-fold-higher titers than ARM/WE-, ARM/ARM-, or WE/WE-infected mice at days 2 to 8 after infection (Fig. 2B ). Interferon was detectable in serum samples from days 1 to 6 after infection, but there were no clear-cut differences between the four genotypes (titers ranged from 100 to 500 I.U./ml). Pathogenic mechanisms. (i) Cytotoxic T lymphocytes do not play a role in the disease after infection with the WE/ARM genotype. The lethal disease observed in adult mice after intracerebral LCMV infection is likely to be primarily mediated by cytotoxic T lymphocytes (29) . Therefore, we determined whether such effector lymphocytes were generated and caused the death of neonates infected with the WE/ARM genotype. Single-cell populations from a pool of four to six spleens were taken from 8-to 10-day-old mice uninfected or infected at birth with the ARM/ARM, WE/WE, ARM/WE, or WE/ARM genotype. Such effector cells failed to lyse syngeneic target cells infected with LCMV ARM (Fig. 3) . In contrast, effector cells harvested from 6-to 8-week-old BALB/c WEHI mice infected 7 days previously with LCMV ARM killed LCMV-infected H-2-restricted target cells. In other experiments, BALB/c WEHI congenitally athymic mice were inoculated with the WE/ARM genotype or either parental virus. Although less than 5% mortality was noted in ARM/ARM-or WE/WE-infected mice, 21 (88%) of 26 mice inoculated with WE/ARM died. Death occurred by day 6 to 14 after viral inoculation. Furthermore, these athymic mice showed both growth retardation and lesions of extensive liver necrosis. Again, other tissues (i.e., brain, spleen, etc.) showed no evidence of necrosis. In toto, these results exclude a role for cytotoxic T lymphocytes in the mortality of newborn mice infected with the WE/ARM virus.
(ii) Endogenous interferon is responsible for liver necrosis and death after infection of BALB/c WEHI neonates with LCMV WE/ARM. Gresser (18, 19) . Because of the similarity of this syndrome to the disease that follows infection of neonatal BALB/c WEHI mice with the WE/ARM or TRAUB/ARM genotype, we investigated the effect of anti-interferon globulin on such mice. Newborn BALB/c WEHI mice inoculated intracerebrally with 103 PFU of LCMV, WE/ARM genotype, were injected subcutaneously at birth (day 0) and on day 3 with 0.05 ml of a 1:3 dilution of a sheep anti-mouse interferon globulin not containing antibodies to interferon (NIH G024501568) or with an equivalent dilution of sheep globulin not containing antibodies to interferon (NIH G025501568) as a control. Uninfected mice and infected but untreated mice were included in the same experiment. All the virus-infected control mice (11 of 11) and all the virus-infected and mock-treated mice (18 of 18) died between days 8 and 27 after infection, whereas only 1 (5%) of 19 infected, anti-interferon-treated mice died during the testing period (Table 3 ). Figure 4 illustrates the inhibited growth of infected BALB/c mice treated with normal sheep globulin or untreated. Also demonstrated is the growth of mice infected with virus and treated with antibody to interferon, which equaled the growth of uninfected mice.
In a pool of sera collected 3 days after infection, interferon was present when the mice had been infected and treated with control globulin (80 U/ml) but not when they had been infected and treated with anti-mouse interferon globulin. In the same pool of sera, the virus titers were, respectively, 105
and 108 PFU/ml. In a separate experiment, the mean value ± the standard error of the serum virus titers from four sera, 3 days after infection, was 1 treated with anti-mouse interferon globulin. At day 9 after infection, the titers of a pool of sera were 106 0 and 105.9 for the WE/ARM-infected mice treated with, respectively, the control globulin or the anti-mouse interferon globulin. Liver lesions developed in WE/ARM-infected mice that had been untreated or treated with the control globulin preparation; WE/ARM-infected mice treated with the anti-mouse interferon globulin had no such lesions.
DISCUSSION
The occurrence and severity of an infectious disease reflect a delicate balance between a susceptible host and a virulent microbe. In this paper we have shown first, that parental viruses, avirulent for a specific host, become viru- Reassortants of the WE/ARM or TRAUB/ARM LCMV genotype inoculated into neonatal BALB/c mice caused lethal disease, but the parental LCMV strains (ARM/ARM, WE/WE, and TRAUB/TRAUB) or reciprocal reassortants (ARM/ITRAUB and ARM/WE) did not cause lethal disease. These results occurred with amounts of virus ranging from 102 to 104 PFU per animal (unpublished results). The increased pathogenicity of reassortant viruses derived from less-or nonpathogenic parents has also been observed with some other segmented viruses. For example, Scholtissek et al. (21, 26) reported that mixed infections with various nonneurovirulent or weakly neurovirulent influenza A strains yielded recombinants that were highly neurovirulent for mice. Rubin and Fields (20) found that a chymotrypsinresistant M2 genome segment from reovirus serotype 1 combined with the neurovirulent Si genome segment from serotype 3 was considerably more neurovirulent when administered into the stomach than was either of the parental genotypes. In our experiments, neonates infected with the WE/ARM or TRAUB/ARM reassortants died within 3 weeks after birth, with retarded growth and extensive liver necrosis. However, infection by the parental strains or the reciprocal reassortants failed to cause disease. Furthermore, the few (3 to 4%) of BALB/c WEHI mice that died after infection with ARM/ARM or TRAUB/TRAUB failed to show either liver lesions or growth retardation. Consequently, the overwhelming disease caused by WE/ARM or TRAUB/ARM infection was unexpected. Because the lethal disease after intracerebral infection of adult mice has been related to the induction of cytotoxic T lymphocytes (29) , we looked for such activity in spleens of 8-day-old BALB/c WEHI mice infected at birth with the ARM/ARM, WE/WE, ARM/WE, or WE/ARM genotype. No cytotoxic activity was found in splenic lymphocytes harvested from any of these groups; thus any role for such T cells in the disease incited by LCMV WE/ARM was dismissed. This conclusion was enforced by the observation that 88% (21 of 26) of the BALB/c WEHI nulnu neonates died 6 to 14 days after infection with WE/ARM and had a similar picture of extensive liver necrosis and growth retardation.
Gresser et al. (7) demonstrated that daily inoculation of certain newborn mouse strains with potent interferon preparations results in inhibition of growth, liver cell degeneration, and death. A few years later, Riviere et al. reported (18, 19) that newborn mice injected at birth with LCMV (Pasteur strain, CIPV76001) grew poorly and began to die after the first week of life. The only histopathological lesions observed were in the liver, which showed steatosis and focal or diffuse necrosis. On the contrary, similarly infected mice treated with mouse anti-interferon antibody grew normally and had no liver lesions, and the incidence of death was decreased. The authors concluded that endogenous interferon induced after neonate infection with the Pasteur strain of LCMV was in large part responsible for the manifestations of this acute LCMV disease and for the death of suckling mice. Because of the similarity of that syndrome with our observations of WE/ARM-and TRAUB/ARMinfected BALB/c WEHI neonates, we studied the role of interferon. Of BALB/c WEHI mice infected at birth with the WE/ARM genotype and treated with the anti-mouse interferon globulin, 95% survived and grew normally, i.e., comparably to control uninfected mice (Table 3 and Fig. 4) . A similar result was obtained in the case of TRAUB/ARM infection: the mortality was 8% (1 of 12) when the mice were infected and treated with anti-interferon globulin (unpublished results), and no liver lesions were observed when the mice were infected with either WE/ARM or TRAUB/ARM and treated with anti-interferon serum. At day 3 after infection with WE/ARM, there was a 1,000-fold-greater amount of infectious virus (108 PFU/ml) in the sera of mice infected and treated with anti-interferon globulin than in control infected mice (105 PFU/ml). Infected, mock-treated mice also had significant levels of mouse interferon-a and -,B in their sera on day 3 after infection, whereas no interferon was detectable at this time in sera of mice infected and given anti-interferon globulin. Thus, the enhanced virus replication, per se, in WE/ARM-infected mice compared with that in mice infected with either parental virus or the reciprocal reassortant ARM/WE (Fig. 2) was not directly responsible for the disease of the former. However, high titers of infectious virus, combined with significant levels of circulating interferon, likely play a role in this syndrome.
Previously we noted that C3H/St, CBA/N, and several other strains of mice, when infected as newborns with ARM/ARM or WE/ARM, developed growth hormone insufficiency leading to retarded growth and hypoglycemia (4, 11, 12, 17) . In this instance, virus replicated to a high degree in anterior pituitary cells, making growth hormone (11, 12) . Liver necrosis did not occur, and treatment with antibodies to mouse interferon failed to alter the disease (11) . Hence, the disease pattern observed during LCMV infection reflects the LCMV genotype, as well as the genetics of the host being infected.
Our results showed that the pathogenic factor in the disease of BALB/c WEHI newborns infected with WE/ARM was the generation of interferon, which caused liver necrosis. The fact that three independently derived reassortant clones of the WE/ARM and TRAUB/ARM genotypes caused this lethal disease but that neither the parental strains nor reciprocal reassortants did so suggests that the S-RNA segment of ARM in concert with the L-RNA segment of WE increases viral replication in BALB/c WEHI neonates. In- terferon is made and apparently interacts with susceptible liver cells of BALB/c WEHI mice during a certain time of differentiation and growth.
Because of our findings, we counsel caution with the use of reassortant viruses as candidates for making vaccines. Furthermore, and more intriguing, the lethal alterations described here could account for unanticipated outbreaks of virulence by several infectious agents. In particular, the outbreak of Lassa fever in Africa may have been related to a natural reassortment in vivo of different isolates of the Lassa virus, another member of the Arenaviridae (10, 14) . Finally, it is worth noting that immunochemical or serological assays would not differentiate the virulent reassortant formed from the avirulent parental strain and, thereby, the reassortant would remain unnoticed. In the studies recorded here, the L RNA of WE, in concert with the S RNA of ARM LCMV, was required for disease, whereas the combination of ARM L-RNA and S-RNA was avirulent. The L RNA encodes for a 180,000 P (likely polymerase) protein that is made in limited amounts during viral replication and is rarely detected during infection. In contrast, the viral proteins detected during infection, i.e., glycoprotein 1, glycoprotein 2, and nucleoprotein, are encoded by the S RNA of LCMV (15) . VOL. 59, 1986 on July 6, 2017 by guest http://jvi.asm.org/ Downloaded from
